Global Influenza Diagnostics Market Outlook, Opportunities And Strategies – Includes Influenza Diagnostics Market Demand
Learn about the global influenza diagnostics market through The Business Research Company, which provides information on influenza diagnostics market size, influenza diagnostics market drivers and restraints, influenza diagnostics market players, the COVID-19 impact on the influenza diagnostics market, and more.
The influenza diagnostics market size is expected to grow from $2.26 billion in 2021 to $3.15 billion in 2026 at a rate of 6.8%. The global influenza diagnostics market size is then expected to grow at a CAGR of 6.8% from 2026 and reach $4.37 billion in 2031.
Increasing healthcare expenditure is predicted to drive the demand for influenza diagnostics.
Request A Sample For The Global Influenza Diagnostics Market Report:
The influenza diagnostics market consists of sales of diagnostic tests and related services by entities (organizations, sole traders and partnerships) that are used to detect and to diagnose influenza. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue and headache.
By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Others
By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Others
By End User: Hospitals and Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Others
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the global influenza diagnostics market, accounting for 34.1% of the total in 2021.
Artificial Intelligence is being increasingly incorporated with rapid diagnostic test kits to increase the efficiency of diagnosis. Artificial intelligence (AI) refers to the simulation of human intelligence in computer-controlled machines that are programmed to perform tasks, which usually require human intelligence. Artificial Intelligence algorithms are being used to integrate the findings of clinical symptoms, exposure history, and laboratory testing to increase the chance of early detection of influenza infection.
TBRC’s Influenza Diagnostics Market Report Covers:
Major Market Players: Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Thermo Fisher Scientific Inc, Quidel Corp
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)
The Influenza Diagnostics Market Report 2022 is one of a series of new reports from The Business Research Company that provides influenza diagnostics market overviews, analyzes and forecasts market size, share, influenza diagnostics market players, influenza diagnostics market segments and geographies, leading competitor revenues, profiles and market shares.
TBRC’s influenza diagnostics market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Here Is A List Of Similar Reports From The Business Research Company:
Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: